Matthew Buckhalter - Jul 7, 2023 Form 3 Insider Report for Aveanna Healthcare Holdings, Inc. (AVAH)

Role
Interim Chief Financial Officer See Exhibit 24.1 - Power of Attorney
Signature
/s/ Shannon Drake, Attorney-in-Fact
Stock symbol
AVAH
Transactions as of
Jul 7, 2023
Transactions value $
$0
Form type
3
Date filed
7/14/2023, 06:17 AM
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVAH Common Stock, par value $0.01 per share 182K Jul 7, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVAH Employee Stock Option (right to buy) Jul 7, 2023 Common Stock 21.3K $4.88 Direct F2
holding AVAH Employee Stock Option (right to buy) Jul 7, 2023 Common Stock 21.3K $4.88 Direct F3
holding AVAH Employee Stock Option (right to buy) Jul 7, 2023 Common Stock 30.8K $15.00 Direct F4
holding AVAH Employee Stock Option (right to buy) Jul 7, 2023 Common Stock 30.8K $15.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes the following stock-settled restricted stock units ("RSUs"): (i) 115,000 RSUs granted on December 29, 2021, subject to 4 year cliff investing, (ii) 12,678 RSUs granted on February 14, 2022, subject to 3 year cliff investing, and (iii) 46,875 RSUs granted on February 14, 2023, subject to 3 year cliff investing.
F2 The options vested ratably on an annual basis over a five-year period that commenced March 16, 2017.
F3 The options become exercisable, if at all, in two equal increments if the average daily closing price of Aveanna Healthcare Holdings Inc.'s (the "Issuer") common stock on the Nasdaq Global Select Market during any 90 consecutive calendar day period, commencing on or after nine (9)-month anniversary of April 28, 2021, exceeds specified volume-weighted average price targets determined by the Issuer's Board of Directors.
F4 The options vest ratably on an annual basis over a five-year period that commenced November 4, 2020.
F5 The options become exercisable, if at all, in two equal increments if the average daily closing price of the Issuer's common stock on the Nasdaq Global Select Market during any 90 consecutive calendar day period, commencing on or after nine (9)-month anniversary of April 28, 2021, exceeds specified volume-weighted average price targets determined by the Issuer's Board of Directors

Remarks:

Interim Chief Financial Officer See Exhibit 24.1 - Power of Attorney